108 related articles for article (PubMed ID: 27130219)
21. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs.
Van Oosterhout AJ; Ladenius AR; Savelkoul HF; Van Ark I; Delsman KC; Nijkamp FP
Am Rev Respir Dis; 1993 Mar; 147(3):548-52. PubMed ID: 8442585
[TBL] [Abstract][Full Text] [Related]
22. Relaxant effect of YM976, a novel phosphodiesterase 4 inhibitor, on bovine tracheal smooth muscle.
Moriuchi H; Nakahara T; Maruko T; Sakamoto K; Ishii K
Eur J Pharmacol; 2003 May; 470(1-2):57-64. PubMed ID: 12787831
[TBL] [Abstract][Full Text] [Related]
23. PDE4 inhibition and a corticosteroid in chronically antigen exposed conscious guinea-pigs.
Danahay H; Broadley KJ
Clin Exp Allergy; 1998 Apr; 28(4):513-22. PubMed ID: 9641581
[TBL] [Abstract][Full Text] [Related]
24. Quercetin acutely relaxes airway smooth muscle and potentiates β-agonist-induced relaxation via dual phosphodiesterase inhibition of PLCβ and PDE4.
Townsend EA; Emala CW
Am J Physiol Lung Cell Mol Physiol; 2013 Sep; 305(5):L396-403. PubMed ID: 23873842
[TBL] [Abstract][Full Text] [Related]
25. Effects of a selective PDE4 inhibitor, D-22888, on human airways and eosinophils in vitro and late phase allergic pulmonary eosinophilia in guinea pigs.
Dent G; Poppe H; Egerland J; Marx D; Szelenyi I; Branscheid D; Magnussen H; Rabe KF
Pulm Pharmacol Ther; 1998 Feb; 11(1):13-21. PubMed ID: 9802959
[TBL] [Abstract][Full Text] [Related]
26. The in vivo pharmacology of CP-80, 633, a selective inhibitor of phosphodiesterase 4.
Turner CR; Cohan VL; Cheng JB; Showell HJ; Pazoles CJ; Watson JW
J Pharmacol Exp Ther; 1996 Sep; 278(3):1349-55. PubMed ID: 8819522
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic effects of naringin in a guinea pig model of ovalbumin-induced cough-variant asthma.
Jiao HY; Su WW; Li PB; Liao Y; Zhou Q; Zhu N; He LL
Pulm Pharmacol Ther; 2015 Aug; 33():59-65. PubMed ID: 26169899
[TBL] [Abstract][Full Text] [Related]
28. In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor.
Bundschuh DS; Eltze M; Barsig J; Wollin L; Hatzelmann A; Beume R
J Pharmacol Exp Ther; 2001 Apr; 297(1):280-90. PubMed ID: 11259555
[TBL] [Abstract][Full Text] [Related]
29. Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor.
Aoki M; Fukunaga M; Sugimoto T; Hirano Y; Kobayashi M; Honda K; Yamada T
J Pharmacol Exp Ther; 2001 Sep; 298(3):1142-9. PubMed ID: 11504812
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors.
Wollin L; Bundschuh DS; Wohlsen A; Marx D; Beume R
Pulm Pharmacol Ther; 2006; 19(5):343-52. PubMed ID: 16257550
[TBL] [Abstract][Full Text] [Related]
31. Selective inhibitors for phosphodiesterase 3 and 4 in antigen-induced increase of cough reflex sensitivity in guinea pigs.
Fujimura M; Liu Q
Pulm Pharmacol Ther; 2007; 20(5):543-8. PubMed ID: 16829147
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of airway inflammation, hyperresponsiveness and remodeling by soy isoflavone in a murine model of allergic asthma.
Bao ZS; Hong L; Guan Y; Dong XW; Zheng HS; Tan GL; Xie QM
Int Immunopharmacol; 2011 Aug; 11(8):899-906. PubMed ID: 21354484
[TBL] [Abstract][Full Text] [Related]
33. Effects of L-arginine and phosphodiesterase-5 inhibitor, sildenafil, on inflammation and airway responsiveness of sensitized BP2 mice.
Al Qadi-Nassar B; Bichon-Laurent F; Portet K; Tramini P; Arnoux B; Michel A
Fundam Clin Pharmacol; 2007 Dec; 21(6):611-20. PubMed ID: 18034662
[TBL] [Abstract][Full Text] [Related]
34. A novel phosphodiesterase type 4 inhibitor, YM976 (4-(3-chlorophenyl)-1,7-diethylpyrido[2,3-d]pyrimidin-2(1H)-one), with little emetogenic activity.
Aoki M; Kobayashi M; Ishikawa J; Saita Y; Terai Y; Takayama K; Miyata K; Yamada T
J Pharmacol Exp Ther; 2000 Oct; 295(1):255-60. PubMed ID: 10991987
[TBL] [Abstract][Full Text] [Related]
35. Antitussive activity of Althaea officinalis L. polysaccharide rhamnogalacturonan and its changes in guinea pigs with ovalbumine-induced airways inflammation.
Sutovska M; Capek P; Franova S; Joskova M; Sutovsky J; Marcinek J; Kalman M
Bratisl Lek Listy; 2011; 112(12):670-5. PubMed ID: 22372330
[TBL] [Abstract][Full Text] [Related]
36. Effects of flavin7 on allergen induced hyperreactivity of airways.
Franova S; Joskova M; Novakova E; Adamicova K; Sutovska M; Nosal S
Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):78-81. PubMed ID: 20156731
[TBL] [Abstract][Full Text] [Related]
37. Effect of a novel anti-inflammatory compound, YM976, on antigen-induced eosinophil infiltration into the lungs in rats, mice, and ferrets.
Aoki M; Fukunaga M; Kitagawa M; Hayashi K; Morokata T; Ishikawa G; Kubo S; Yamada T
J Pharmacol Exp Ther; 2000 Dec; 295(3):1149-55. PubMed ID: 11082452
[TBL] [Abstract][Full Text] [Related]
38. Suppression of ovalbumin-induced Th2-driven airway inflammation by β-sitosterol in a guinea pig model of asthma.
Mahajan SG; Mehta AA
Eur J Pharmacol; 2011 Jan; 650(1):458-64. PubMed ID: 20946894
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the cough reflex and airway reactivity in toluene- and ovalbumin-induced airway hyperresponsiveness.
Mokry J; Nosalova G
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):419-26. PubMed ID: 18204154
[TBL] [Abstract][Full Text] [Related]
40. The pharmacology of two novel long-acting phosphodiesterase 3/4 inhibitors, RPL554 [9,10-dimethoxy-2(2,4,6-trimethylphenylimino)-3-(n-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one] and RPL565 [6,7-dihydro-2-(2,6-diisopropylphenoxy)-9,10-dimethoxy-4H-pyrimido[6,1-a]isoquinolin-4-one].
Boswell-Smith V; Spina D; Oxford AW; Comer MB; Seeds EA; Page CP
J Pharmacol Exp Ther; 2006 Aug; 318(2):840-8. PubMed ID: 16682455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
